Viewing Study NCT04573556


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-03-29 @ 7:03 AM
Study NCT ID: NCT04573556
Status: COMPLETED
Last Update Posted: 2022-04-05
First Post: 2020-09-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety of DAYVIGO (Lemborexant) Tablets in Participants With Insomnia.
Sponsor: Eisai Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module